SINGAPORE’S ANNUAL MEETING ON BIOSIMILARS,

About the event

Masaki Iino MD, PhD
University of Yamanashi, Japan

Silvia Brandalise
Centro Infantil Boldrini, Brazil

Balkiss Bouhaouala
Medicine of Tunis, Biochemistry, Tunisia

Prof.Eva Rahman Kabir, PhD
BRAC University, Bangladesh

Why should you sponsor?

• An opportunity to promote your organisation and raise your profile within the wider community;
• Promote your company name to national and international participants prior to, during and after the Conference, these include decision makers, scientists, students and community members;
• Your representative can mix informally with professionals from industry and academia from all around the world;
• Your company support of the Conference will be acknowledged widely through web-based and printed material;

Program Manager

Key Discussions on Biosimilars 2019

• Current regulatory status of biosimilar medicines in the EU
• Market access and regulatory developments
• Sustainability of the biosimilar medicines sector
• Advances and convergence of regulatory science
• Regulatory requirements, scientific and operational challenges
• Biosimilar Development and Manufacturing
• Pharmacovigilance
• Clinical Trials
• Legal Considerations on Biosimilars
• FDA-Approved biosimilar products
• Prescribing biosimilar and generics drugs

Contact the Organizer Contact the Organizer